ERBB2 and breast carcinoma: Each of the subtypes present (Luminal A/B, Basal, Claudin Low, HER2 + ve and normal like) have a unique transcriptomic profile, resulting in the dysregulation in key proteins in breast cancer, including the alteration of the E2F family of transcription factors3–7.